Total Payments
$106,510
2024 Payments
$15,155
Companies
39
Transactions
320
Medicare Patients
2,322
Medicare Billing
$1.3M
Payment Breakdown by Category
Consulting$32,175 (30.2%)
Education$32,134 (30.2%)
Travel$18,781 (17.6%)
Other$15,613 (14.7%)
Food & Beverage$7,807 (7.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $32,175 | 16 | 30.2% |
| Education | $32,134 | 22 | 30.2% |
| Travel and Lodging | $18,781 | 23 | 17.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15,613 | 7 | 14.7% |
| Food and Beverage | $7,807 | 252 | 7.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $38,217 | 48 | $0 (2023) |
| Clovis Oncology, Inc. | $26,836 | 34 | $0 (2020) |
| Momentis Surgical Inc. | $26,245 | 13 | $0 (2024) |
| Memic Innovative Surgery Inc. | $8,952 | 13 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $2,391 | 36 | $0 (2024) |
| Daiichi Sankyo Inc. | $404.88 | 46 | $0 (2024) |
| TESARO, Inc. | $388.34 | 20 | $0 (2019) |
| Merck Sharp & Dohme LLC | $356.13 | 16 | $0 (2024) |
| Genmab U.S., Inc. | $354.16 | 8 | $0 (2024) |
| ABBVIE INC. | $280.91 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15,155 | 28 | Momentis Surgical Inc. ($12,712) |
| 2023 | $15,190 | 45 | Momentis Surgical Inc. ($13,533) |
| 2022 | $11,202 | 49 | Memic Innovative Surgery Inc. ($8,952) |
| 2021 | $4,181 | 4 | Intuitive Surgical, Inc. ($4,150) |
| 2020 | $8,988 | 28 | Clovis Oncology, Inc. ($4,293) |
| 2019 | $21,523 | 72 | Intuitive Surgical, Inc. ($13,013) |
| 2018 | $26,048 | 66 | Intuitive Surgical, Inc. ($14,051) |
| 2017 | $4,222 | 28 | Clovis Oncology, Inc. ($3,533) |
All Payment Transactions
320 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Genmab U.S., Inc. | Tivdak (Drug) | Food and Beverage | In-kind items and services | $33.52 | General |
| Category: Oncology | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $29.30 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $1,675.00 | General |
| 11/12/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | Momentis Surgical Inc. | ANOVA SURGICAL SYSTEM (Drug) | Travel and Lodging | Cash or cash equivalent | $607.36 | General |
| Category: SURGERY | ||||||
| 11/07/2024 | Momentis Surgical Inc. | ANOVA SURGICAL SYSTEM (Drug) | Travel and Lodging | Cash or cash equivalent | $12,051.00 | General |
| Category: SURGERY | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Oncology | ||||||
| 09/28/2024 | Spectrum Pharmaceuticals Inc. | ROLVEDON (Drug) | Food and Beverage | In-kind items and services | $162.42 | General |
| Category: Oncology | ||||||
| 09/18/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: ONCOLOGY | ||||||
| 09/17/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $29.12 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 09/05/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Oncology | ||||||
| 08/11/2024 | Momentis Surgical Inc. | ANOVA SURGICAL SYSTEM (Drug) | Food and Beverage | Cash or cash equivalent | $54.01 | General |
| Category: SURGERY | ||||||
| 08/02/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $33.01 | General |
| Category: ONCOLOGY | ||||||
| 07/29/2024 | Spectrum Pharmaceuticals Inc. | ROLVEDON (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Oncology | ||||||
| 07/18/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Biological | ||||||
| 05/23/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: ONCOLOGY | ||||||
| 05/17/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Oncology | ||||||
| 05/01/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: ONCOLOGY | ||||||
| 04/12/2024 | Genmab U.S., Inc. | Tivdak (Drug) | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: Oncology | ||||||
| 04/12/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: Iron Deficiency Anemia | ||||||
| 02/29/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $29.56 | General |
| Category: Iron Deficiency Anemia | ||||||
| 02/09/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Oncology | ||||||
| 02/08/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $2.59 | General |
| Category: Oncology | ||||||
| 02/01/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 484 | 8,782 | $351,019 | $74,679 |
| 2022 | 23 | 618 | 14,987 | $439,422 | $85,266 |
| 2021 | 24 | 574 | 22,890 | $1.5M | $479,260 |
| 2020 | 26 | 646 | 39,457 | $1.7M | $612,404 |
Total Patients
2,322
Total Services
86,116
Medicare Billing
$1.3M
Procedure Codes
90
All Medicare Procedures & Services
90 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 85 | 181 | $63,350 | $22,456 | 35.4% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 25 | 124 | $51,088 | $11,991 | 23.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 89 | 128 | $35,275 | $10,601 | 30.1% |
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2023 | 16 | 16 | $56,000 | $10,495 | 18.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 58 | 58 | $29,000 | $9,045 | 31.2% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 19 | 164 | $16,400 | $3,522 | 21.5% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 13 | 37 | $7,474 | $1,811 | 24.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 35 | 127 | $4,064 | $943.64 | 23.2% |
| J1453 | Injection, fosaprepitant, 1 mg | Office | 2023 | 16 | 6,300 | $31,500 | $782.31 | 2.5% |
| 36591 | Collection of blood sample from implanted device | Office | 2023 | 11 | 39 | $2,340 | $762.84 | 32.6% |
| J9045 | Injection, carboplatin, 50 mg | Office | 2023 | 15 | 374 | $22,440 | $727.96 | 3.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 25 | 71 | $3,550 | $724.50 | 20.4% |
| J2469 | Injection, palonosetron hcl, 25 mcg | Office | 2023 | 18 | 460 | $23,920 | $375.29 | 1.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 16 | 27 | $270.00 | $226.80 | 84.0% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 13 | 34 | $1,020 | $133.96 | 13.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 18 | 619 | $3,098 | $59.74 | 1.9% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2023 | 12 | 23 | $230.00 | $19.71 | 8.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 89 | 174 | $60,900 | $23,060 | 37.9% |
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2022 | 20 | 20 | $70,000 | $13,891 | 19.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 25 | 135 | $55,620 | $13,572 | 24.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 56 | 56 | $28,000 | $9,400 | 33.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 68 | 98 | $26,950 | $8,524 | 31.6% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2022 | 20 | 293 | $29,300 | $6,986 | 23.8% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2022 | 12 | 32 | $6,464 | $1,484 | 23.0% |
| J1453 | Injection, fosaprepitant, 1 mg | Office | 2022 | 19 | 10,050 | $50,250 | $1,343 | 2.7% |
About Dr. Thomas Heffernan, MD
Dr. Thomas Heffernan, MD is a Obstetrics & Gynecology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326148651.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Heffernan, MD has received a total of $106,510 in payments from pharmaceutical and medical device companies, with $15,155 received in 2024. These payments were reported across 320 transactions from 39 companies. The most common payment nature is "Consulting Fee" ($32,175).
As a Medicare-enrolled provider, Heffernan has provided services to 2,322 Medicare beneficiaries, totaling 86,116 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 90 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Other Specialties Gynecologic Oncology
- Location Dallas, TX
- Active Since 09/25/2006
- Last Updated 03/20/2023
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1326148651
Products in Payments
- Da Vinci Surgical System (Device) $38,217
- Rubraca (Drug) $26,822
- Anovo Surgical System (Device) $22,485
- ANOVA SURGICAL SYSTEM (Drug) $12,712
- LYNPARZA (Drug) $709.03
- ZEJULA (Drug) $481.33
- Tivdak (Drug) $338.06
- KEYTRUDA (Biological) $335.34
- INJECTAFER (Drug) $276.70
- PRECISETUMOR (Device) $228.29
- Avastin (Biological) $202.37
- ROLVEDON (Drug) $183.25
- ELAHERE (Drug) $151.84
- Orilissa (Drug) $151.56
- FOUNDATIONONE (Device) $100.06
- Udenyca (Biological) $91.07
- Neulasta (Biological) $89.61
- ENHERTU (Drug) $82.24
- ORILISSA (Drug) $78.42
- SUSTOL (Drug) $74.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Dallas
Dustin Manders, Md, MD
Obstetrics & Gynecology — Payments: $141,025
Obstetrics & Gynecology $141,025
Dr. Yolanda Lawson, M.d, M.D
Obstetrics & Gynecology — Payments: $106,589
Obstetrics & Gynecology $106,589
Dr. Kamilia Smith, M.d, M.D
Obstetrics & Gynecology — Payments: $89,030
Obstetrics & Gynecology $89,030
Satin Patel, M.d, M.D
Obstetrics & Gynecology — Payments: $54,616
Obstetrics & Gynecology $54,616
Quanita Crable, Md, MD
Obstetrics & Gynecology — Payments: $45,700
Obstetrics & Gynecology $45,700
Mark Godat, M.d, M.D
Obstetrics & Gynecology — Payments: $36,377
Obstetrics & Gynecology $36,377